HOOKIPA Pharma Inc
NASDAQ:HOOK
Income Statement
Earnings Waterfall
HOOKIPA Pharma Inc
Revenue
|
53.6m
USD
|
Operating Expenses
|
-103.5m
USD
|
Operating Income
|
-49.9m
USD
|
Other Expenses
|
2.4m
USD
|
Net Income
|
-47.5m
USD
|
Income Statement
HOOKIPA Pharma Inc
Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||
Revenue |
8
N/A
|
10
+29%
|
13
+34%
|
13
+1%
|
12
-11%
|
13
+12%
|
16
+20%
|
18
+12%
|
20
+8%
|
21
+8%
|
20
-6%
|
20
-1%
|
18
-6%
|
15
-21%
|
12
-18%
|
10
-14%
|
14
+38%
|
16
+12%
|
16
0%
|
21
+29%
|
20
-2%
|
54
+166%
|
|
Operating Income | |||||||||||||||||||||||
Operating Expenses |
(29)
|
(35)
|
(45)
|
(53)
|
(63)
|
(66)
|
(65)
|
(69)
|
(73)
|
(81)
|
(90)
|
(95)
|
(100)
|
(97)
|
(94)
|
(92)
|
(87)
|
(92)
|
(95)
|
(101)
|
(105)
|
(103)
|
|
Selling, General & Administrative |
(7)
|
(8)
|
(11)
|
(15)
|
(18)
|
(20)
|
(20)
|
(20)
|
(20)
|
(18)
|
(19)
|
(18)
|
(19)
|
(18)
|
(18)
|
(18)
|
(20)
|
(19)
|
(18)
|
(18)
|
(20)
|
(18)
|
|
Research & Development |
(22)
|
(27)
|
(34)
|
(39)
|
(45)
|
(46)
|
(44)
|
(49)
|
(53)
|
(63)
|
(71)
|
(76)
|
(81)
|
(79)
|
(76)
|
(73)
|
(67)
|
(73)
|
(77)
|
(83)
|
(85)
|
(86)
|
|
Depreciation & Amortization |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(21)
N/A
|
(25)
-20%
|
(32)
-26%
|
(40)
-25%
|
(51)
-28%
|
(53)
-4%
|
(49)
+8%
|
(51)
-6%
|
(53)
-4%
|
(60)
-13%
|
(70)
-17%
|
(75)
-7%
|
(82)
-9%
|
(83)
-1%
|
(82)
+1%
|
(82)
+0%
|
(73)
+10%
|
(76)
-3%
|
(79)
-4%
|
(80)
-2%
|
(85)
-6%
|
(50)
+41%
|
|
Pre-Tax Income | |||||||||||||||||||||||
Interest Income Expense |
(1)
|
(1)
|
(0)
|
0
|
1
|
1
|
1
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
1
|
2
|
3
|
5
|
5
|
5
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(13)
|
(14)
|
|
Total Other Income |
6
|
5
|
5
|
5
|
7
|
7
|
8
|
9
|
10
|
10
|
10
|
9
|
7
|
7
|
7
|
8
|
8
|
7
|
7
|
7
|
12
|
11
|
|
Pre-Tax Income |
(16)
N/A
|
(21)
-30%
|
(27)
-29%
|
(35)
-27%
|
(43)
-24%
|
(45)
-4%
|
(40)
+11%
|
(42)
-6%
|
(44)
-5%
|
(50)
-14%
|
(60)
-20%
|
(67)
-11%
|
(76)
-13%
|
(76)
-1%
|
(76)
+1%
|
(74)
+2%
|
(65)
+12%
|
(66)
-2%
|
(68)
-3%
|
(69)
-1%
|
(81)
-18%
|
(47)
+42%
|
|
Net Income | |||||||||||||||||||||||
Tax Provision |
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(16)
|
(21)
|
(27)
|
(35)
|
(43)
|
(45)
|
(40)
|
(42)
|
(44)
|
(50)
|
(60)
|
(67)
|
(76)
|
(76)
|
(76)
|
(74)
|
(65)
|
(67)
|
(68)
|
(69)
|
(82)
|
(48)
|
|
Net Income (Common) |
(16)
N/A
|
(21)
-29%
|
(27)
-30%
|
(35)
-27%
|
(43)
-24%
|
(45)
-4%
|
(40)
+11%
|
(42)
-6%
|
(44)
-5%
|
(50)
-14%
|
(60)
-20%
|
(67)
-11%
|
(76)
-13%
|
(76)
-1%
|
(76)
+1%
|
(74)
+2%
|
(65)
+12%
|
(67)
-3%
|
(68)
-2%
|
(69)
-1%
|
(82)
-18%
|
(48)
+42%
|
|
EPS (Diluted) |
-0.64
N/A
|
-0.83
-30%
|
-1.08
-30%
|
-1.37
-27%
|
-1.68
-23%
|
-1.76
-5%
|
-1.56
+11%
|
-1.64
-5%
|
-1.69
-3%
|
-1.69
N/A
|
-1.84
-9%
|
-2.03
-10%
|
-2.3
-13%
|
-1.97
+14%
|
-1.38
+30%
|
-1.34
+3%
|
-0.99
+26%
|
-1.21
-22%
|
-0.82
+32%
|
-0.82
N/A
|
-0.86
-5%
|
-0.37
+57%
|